Frontlight ResearchEarly access
Metastatic breast cancer trials in United States
222 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleTumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast or Lung Cancer
- Where
- Jacksonville
- Age
- 18 years and over
- People
- 5
- Run by
- Mayo Clinic
See details and how to joinNCT05746325 - Phase 3Taking peopleSaruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer
- Where
- Arlington Heights, Aurora, Baltimore, Boston, Brooklyn, Camden, Chattanooga, Chicago, Dearborn, Detroit, Evanston, Fountain Valley, Gilbert, Glendale, Grand Junction, Hershey, Hollywood, Houston, Indianapolis, Jacksonville, Los Angeles, Louisville, Midlothian, Milwaukee, Mineola, Morgantown, Nashville, New Brunswick, New Hyde Park, Newport Beach, New York, Norfolk, Orlando, Park Ridge, Philadelphia, Pittsburgh, Rochester, Royal Oak, Saint Joseph, San Antonio, Schaumburg, Shirley, Silver Spring, Springfield, St Louis, Stony Brook, Tacoma, The Bronx, Urbana, Westbury, West Columbia, Winfield
- Age
- 18 years and over
- People
- 788 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06380751 · EU 2023-504180-16-00 - No phaseTaking peopleCancer Experience Registry (CER) for Cancer Patients and Caregivers
- Where
- Washington D.C.
- Age
- 18 years and over
- People
- 15,000
- Run by
- Cancer Support Community, Research and Training Institute, Philadelphia
See details and how to joinNCT02333604 - Phase 2Not yet taking people in United StatesTargeting Aurora A Kinase to Overcome Treatment Resistance in Advanced HR+/HER2+ Breast Cancer
- Where
- Madison
- Age
- 18 years and over
- People
- 10
- Run by
- University of Wisconsin, Madison
See details and how to joinNCT07706179 - Phase 2Taking peopleProspective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- Where
- Baltimore, St Louis, Winston-Salem
- Age
- 18 years and over
- People
- 16
- Run by
- Wake Forest University Health Sciences
See details and how to joinNCT02422641 - Phase 3Taking peopleA Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy
- Where
- Amarillo, Atlanta, Boston, Bryn Mawr, Camden, Canton, Charlotte, Dallas, Denver, Detroit, Easton, El Paso, Flower Mound, Fort Worth, Grand Rapids, Greeley, Greenbrae, Kennewick, Kingwood, Los Alamitos, Los Angeles, Louisville, McKinney, Medford, Norwich, Orange, Palm Bay, Paoli, Sacramento, Saint Paul, West Chester, Weston, Winston-Salem, Wynnewood, York
- Age
- 18 years and over
- People
- 420 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT05646862 · EU 2022-502322-41-00 - Phase 1/2Taking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Amarillo, Chattanooga, Dallas, Fairfax, Germantown, Los Angeles, Minneapolis, Nashville, New York, Pearland, Salt Lake City, Skokie, Wenatchee, Westbury, White Plains, Whittier
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - Phase 2Taking peopleEvaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease
- Where
- Cleveland, Columbus, Dallas, Santa Monica, Tampa
- Age
- 18 years and over
- People
- 90 worldwide
- Run by
- Delcath Systems Inc.
See details and how to joinNCT06875128 · EU 2025-521966-91-00 - Phase 3Taking peopleA Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
- Where
- Aberdeen, Abilene, Allen, Amarillo, Anaheim, Anchorage, Annapolis, Arlington, Atlanta, Aurora, Austin, Baltimore, Bethesda, Big Rapids, Boston, Boulder, Bozeman, Brandywine, Burnsville, Camarillo, Centennial, Centralia, Chandler, Charleston, Chesapeake, City of Saint Peters, Clemmons, Colorado Springs, Columbia, Conroe, Coon Rapids, Creve Coeur, Denison, Denton, Denver, Derby, Detroit, Edina, Elmhurst, El Paso, Englewood, Evanston, Fairfax, Fairfield, Fayetteville, Florissant, Flower Mound, Fountain Valley, Fredericksburg, Germantown, Gilbert, Glastonbury, Glendale, Goodyear, Grand Rapids, Green Bay, Greenwich, Guilford, Hackensack, Harlingen, Hartford, Henderson, Hinsdale, Holland, Houston, Irving, Kansas City, Lacey, Lakewood, Largo, Las Vegas, League City, Lewisville, Littleton, Lone Tree, Longmont, Longview, Los Angeles, Louisville, Manassas, Maple Grove, Maplewood, McAllen, McKinney, Mechanicsville, Mesa, Midland, Midlothian, Milwaukee, Minneapolis, Mt. Pleasant, Naperville, Nashville, New Braunfels, New Haven, New Lenox, New Orleans, Newton, Norfolk, North Charleston, North Haven, Norton Shores, Oak Lawn, Odessa, Oxnard, Palestine, Palo Alto, Paris, Park Ridge, Phoenix, Plymouth, Pueblo, Reno, Reston, Richmond, Rochester, Rockville, Rogers, Salt Lake City, San Antonio, Santa Barbara, Savannah, Scottsdale, Seattle, Shiloh, Silver Spring, Skokie, Solvang, Springdale, Stamford, St Louis, Sugar Land, Summerville, Thornton, Torrance, Torrington, Trumbull, Tyler, Van Nuys, Ventura, Virginia Beach, Waco, Washington D.C., Waterbury, Waterford, Weslaco, Wichita Falls, Williamsburg, Winston-Salem, Woodbury
- Age
- 18 years and over
- People
- 400 worldwide
- Run by
- Pfizer
See details and how to joinNCT07062965 · EU 2025-520566-22-00 - Phase 3Taking peopleA Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
- Where
- Duarte, Edgewood, Evanston, Fort Worth, Kingwood, Louisville, Marietta, Midlothian, Nashville, Palo Alto, Reno, Sioux Falls
- Age
- 18 years to 130 years
- People
- 150 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07647328 - Phase 2Taking peopleAbemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.
- Where
- Boston, Buffalo, Duarte, Irvine, Long Beach, South Pasadena
- Age
- 70 years and over
- People
- 43
- Run by
- City of Hope Medical Center
See details and how to joinNCT04305834 - No phaseTaking peopleProspective Registry of ADC as First- and Second-line Treatment for Breast Cancer
- Where
- Durham, San Francisco, The Bronx
- Age
- 18 years and over
- People
- 100
- Run by
- University of California, San Francisco
See details and how to joinNCT06774027 - Phase 1Taking peopleTesting the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
- Where
- Boston, St Louis
- Age
- 18 years and over
- People
- 36
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07137416 - No phaseTaking peopleA Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
- Where
- Arcadia, Duarte, Huntington Beach, Irvine, Lancaster, Long Beach, Santa Clarita, Simi Valley, South Pasadena, Upland, West Covina
- Age
- 18 years and over
- People
- 126
- Run by
- City of Hope Medical Center
See details and how to joinNCT07741968 - Phase 2Taking peopleAnastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer
- Where
- Orange
- Age
- 18 years and over
- People
- 20
- Run by
- University of California, Irvine
See details and how to joinNCT05524584 - Phase 1Taking peopleBGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
- Where
- Columbus, Denver, Detroit, Durham, Houston, Irving, Lake Mary, Nashville, San Antonio
- Age
- 18 years and over
- People
- 433 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT06120283 · EU 2023-506888-34-00 - Phase 1Not yet taking people in United StatesMTX-531-001 Phase 1 Study in Advanced Solid Tumors
- Where
- Newport Beach
- Age
- 18 years and over
- People
- 71
- Run by
- MEKanistic Therapeutics, Inc.
See details and how to joinNCT07874880 - Phase 3Taking peopleA Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
- Where
- Altamonte Springs, Aurora, Baltimore, Baton Rouge, Boston, Brooklyn, Chandler, Charlotte, Chicago, Columbus, Dallas, Denver, Detroit, Edgewood, Fairfax, Fort Worth, Fullerton, Gainesville, Gilbert, Highlands Ranch, Kansas City, La Jolla, Los Alamitos, Madison, Midlothian, Mineola, New Haven, New York, Nyack, Orlando, Philadelphia, Portland, Richmond, Roanoke, San Antonio, Silver Spring, Stamford, St Louis, Stony Brook, Thomasville, Tyler
- Age
- 18 years and over
- People
- 1,200 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06312176 · EU 2023-504918-29-00 - Phase 1/2Taking peopleZunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis
- Where
- Rochester, St Louis, Westwood
- Age
- 18 years and over
- People
- 152
- Run by
- Washington University School of Medicine
See details and how to joinNCT06374459 - No phaseTaking peopleEnhancing Access to Supportive Services for Women of Color With Metastatic Breast Cancer
- Where
- New York
- Age
- 18 years and over
- People
- 67
- Run by
- Icahn School of Medicine at Mount Sinai
See details and how to joinNCT06405828 - Phase 1/2Taking peoplePhase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- Where
- Boston, Fairfax, Houston, Huntersville, New Haven, Newport Beach, San Antonio, San Francisco, Seattle
- Age
- 18 years and over
- People
- 233 worldwide
- Run by
- Ensem Therapeutics
See details and how to joinNCT06993844 - Phase 3Taking peopleAdding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis
- Where
- Bloomington, Canton, Cape Girardeau, Carthage, Clive, Collierville, Columbus, Decatur, Derby, Des Moines, Eureka, Fairfield, Galesburg, Greenwich, Grenada, Guilford, Hamden, Jonesboro, Kewanee, Macomb, Mechanicsville, Memphis, Midlothian, New Albany, New Haven, North Haven, O'Fallon, Orlando, Ottawa, Oxford, Pekin, Peoria, Peru, Philadelphia, Princeton, Richmond, Springfield, Stamford, Torrington, Trumbull, Washington, Waterbury, Waterford, West Columbia, West Des Moines, Westerly, Wichita, Willow Grove
- Age
- 18 years and over
- People
- 562
- Run by
- SWOG Cancer Research Network
See details and how to joinNCT07578116 - No phaseTaking peopleBettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer
- Where
- St Louis
- Age
- 18 years and over
- People
- 145
- Run by
- Washington University School of Medicine
See details and how to joinNCT05977036 - Phase 3Taking peoplePhase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
- Where
- Aurora, Bethesda, Billings, Boston, Columbus, Detroit, Duarte, Fort Worth, Fullerton, Houston, Jonesboro, Kansas City, Little Rock, Los Angeles, Midlothian, New York, Paducah, Philadelphia, Pittsburgh, Plantation, Portland, Redondo Beach, San Antonio, San Diego, Santa Fe, Seattle, St Louis, Tamarac, Westbury, Westwood
- Age
- 18 years and over
- People
- 1,180 worldwide
- Run by
- Celcuity Inc
See details and how to joinNCT06757634 · EU 2024-518933-28-01 - Phase 1Taking peoplePhase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)
- Where
- Houston
- Age
- 18 years and over
- People
- 50
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06545682